What does LISCICOM do?

LISCICOM is a pharmacy in Brugge. Private Limited, started on 30 July 2019, 1 establishment.

What is the address of LISCICOM?

The registered office of LISCICOM is located at Jacob de Meyerestraat 5, 8200 Brugge.

Is LISCICOM still active?

Yes. According to the CBE (29 October 2026) LISCICOM is active, legal situation “Normale toestand”, started on 30 July 2019.

Is LISCICOM registered on Peppol?

Yes, LISCICOM is registered on the Peppol network with ID 0208:0731715342.

What is the enterprise number of LISCICOM?

The enterprise number of LISCICOM is BE0731715342.

When was LISCICOM founded?

LISCICOM was founded on 30 July 2019.

Who are the directors of LISCICOM?

According to the 2025 annual accounts, the directors of LISCICOM are: Ineke Demuylder, Louis Declerck.

Is LISCICOM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 July 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did LISCICOM make in 2025?

LISCICOM posted a profit after taxes of € 11,289 in financial year 2025.

What is the revenue of LISCICOM?

As a small company, LISCICOM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 20,130.

LISCICOM (Private Limited) - Brugge - BE0731715342

Dossier LISCICOM, printed on 29 October 2026 from databakkes.be/en/0731715342/liscicom. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LISCICOM from Brugge, company number BE0731715342, closed financial year 2025 with a result of € 11,289 after tax. For that financial year LISCICOM recorded a gross margin of € 20,130 and equity of € 45,598. Compared with financial year 2024, the result moved from € 29,309 to € 11,289. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 45,598

▲ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 11,289

▼ 61% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5,614

▼ 60% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 40,598.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,982

▲ 132% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,374

▼ 24% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 22,397 Gross margin 2022: € 22,397 First fiscal year in the series	€ 26,197 Gross margin 2023: € 26,197 ▲ 17% vs 2022 (€ 22,397) Favourable step	€ 45,059 Gross margin 2024: € 45,059 ▲ 72% vs 2023 (€ 26,197) Favourable step	€ 20,130 Gross margin 2025: € 20,130 ▼ 55% vs 2024 (€ 45,059) Unfavourable step	▼ 55%
Profit after taxes	€ 13,149 Profit after taxes 2022: € 13,149 First fiscal year in the series	€ 16,645 Profit after taxes 2023: € 16,645 ▲ 27% vs 2022 (€ 13,149) Favourable step	€ 29,309 Profit after taxes 2024: € 29,309 ▲ 76% vs 2023 (€ 16,645) Favourable step	€ 11,289 Profit after taxes 2025: € 11,289 ▼ 61% vs 2024 (€ 29,309) Unfavourable step	▼ 61%
Equity	€ 48,206 Equity 2022: € 48,206 First fiscal year in the series	€ 53,851 Equity 2023: € 53,851 ▲ 12% vs 2022 (€ 48,206) Favourable step	€ 34,309 Equity 2024: € 34,309 ▼ 36% vs 2023 (€ 53,851) Unfavourable step	€ 45,598 Equity 2025: € 45,598 ▲ 33% vs 2024 (€ 34,309) Favourable step	▲ 33%
Total debts	€ 43,985 Total debts 2022: € 43,985 First fiscal year in the series	€ 18,011 Total debts 2023: € 18,011 ▼ 59% vs 2022 (€ 43,985) Favourable step	€ 26,034 Total debts 2024: € 26,034 ▲ 45% vs 2023 (€ 18,011) Unfavourable step	€ 18,328 Total debts 2025: € 18,328 ▼ 30% vs 2024 (€ 26,034) Favourable step	▼ 30%
Cash	€ 26,043 Cash 2022: € 26,043 First fiscal year in the series	€ 15,841 Cash 2023: € 15,841 ▼ 39% vs 2022 (€ 26,043) Unfavourable step	€ 14,159 Cash 2024: € 14,159 ▼ 11% vs 2023 (€ 15,841) Unfavourable step	€ 5,614 Cash 2025: € 5,614 ▼ 60% vs 2024 (€ 14,159) Unfavourable step	▼ 60%
Retained profit	€ 43,206 Retained profit 2022: € 43,206 First fiscal year in the series	€ 48,851 Retained profit 2023: € 48,851 ▲ 13% vs 2022 (€ 43,206) Favourable step	€ 29,309 Retained profit 2024: € 29,309 ▼ 40% vs 2023 (€ 48,851) Unfavourable step	€ 40,598 Retained profit 2025: € 40,598 ▲ 39% vs 2024 (€ 29,309) Favourable step	▲ 39%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 11,000 Dividend 2023: € 11,000 Unchanged (€ 0) Unchanged	€ 48,851 Dividend 2024: € 48,851 ▲ € 37,851 vs 2023 (€ 11,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 48,851) Unchanged	▼ 100%
Balance sheet total	€ 92,190 Balance sheet total 2022: € 92,190 First fiscal year in the series	€ 71,862 Balance sheet total 2023: € 71,862 ▼ 22% vs 2022 (€ 92,190) Unchanged	€ 60,343 Balance sheet total 2024: € 60,343 ▼ 16% vs 2023 (€ 71,862) Unchanged	€ 63,926 Balance sheet total 2025: € 63,926 ▲ 6% vs 2024 (€ 60,343) Unchanged	▲ 6%

Key figures of LISCICOM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LISCICOM?

What happened at LISCICOM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 11,289 (▼ 61% vs 2024). Source: NBB ↗
Jul 30, 2019 New establishment in Brugge. KBO
Jul 30, 2019 Start of the company according to the CBE. KBO

In short

From € 13,149 profit in 2022 to € 11,289 profit in 2025.

Paid € 29,707 in corporate taxes since 2022.

Best year ever: 2024, with € 29,309 profit.

Paid out € 59,851 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Ineke Demuylder Louis Declerck

ERUDITE PHARMA

LISCICOM

T.DIFFUSION

NUTRIPHYT

Behind LISCICOM are Ineke Demuylder and Louis Declerck. The same people are also behind ERUDITE PHARMA. Louis Declerck is also behind T.DIFFUSION, NUTRIPHYT, TRENKER NUTRITION, ERUDITE and Erudite.Health.

Directors

According to the 2025 annual accounts

Ineke Demuylder

Director

Also active at: ERUDITE PHARMA

Louis Declerck

Director

Also active at: T.DIFFUSION, NUTRIPHYT, TRENKER NUTRITION, ERUDITE, ERUDITE PHARMA, Erudite.Health, Trenker HoldCo

Establishments

Establishment units

Physical locations of this company

Registered office

Jacob de Meyerestraat 5

8200 Brugge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ERUDITE same network

€ 137,726 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0731.715.342
VAT number: BE 0731.715.342
Registered office: Jacob de Meyerestraat 5, 8200 Brugge
Names & denominations: LISCICOM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 July 2019
Peppol: Active · Active since 30 Jun 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗